Key Record Dates
ClinicalTrials.gov Identifier: | NCT03345836 |
---|---|
Brief Title: | A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy |
First Submitted : | November 15, 2017 |
First Submitted that Met QC Criteria : | November 15, 2017 |
First Posted : | November 17, 2017 |
Results First Submitted : | July 18, 2022 |
Results First Submitted that Met QC Criteria : | July 18, 2022 |
Results First Posted : | August 15, 2022 |
Last Update Submitted that Met QC Criteria : | July 18, 2022 |
Last Update Posted : | August 15, 2022 |